Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

NCT04278729 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT04278729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04278729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 1
Overall status
Completed
Start date
April 14, 2021
Completion date
September 22, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

membranous nephropathy, nephrotic syndrome